Autori: Schenker Michael
| Naslov | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) (Article) |
| Autori | Pillai Rathi N Fennell Dean A Kovcin Vladimir N Ciuleanu Tudor E Ramlau Rodryg Kowalski Dariusz Schenker Michael Yalcin Ilker Teofilovici Florentina Vukovic Vojo M Ramalingam Suresh S |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 6, str. 613-+ |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study (Article) |
| Autori | Thongprasert Sumitra Geater Sarayut L Clement Dana Abdelaziz Amr Reyes-Igama Jasmin Jovanovic Dragana Alexandru Aurelia Schenker Michael Sriuranpong Virote Serwatowski Piotr Suresh Sheethal Cseh Agnieszka Gaafar Rabab |
| Info | LUNG CANCER MANAGEMENT, (2019), vol. 8 br. 3, str. - |
| Projekat | AstraZeneca; Roche; Boehringer Ingelheim; Novartis; Astra Zeneca; Astellas; Bristol Myers Squibb; Eli Lilly; Pfizer; AbbVie; Merck; Merck Serono; Bioven; Pharma Mar; Regeneron; Eisai; Amgern; Mylan |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
